Welcome to LookChem.com Sign In|Join Free
  • or
1-(4-chlorobenzyl)-1H-pyrrolo[2,3-b]pyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

35965-29-8

Post Buying Request

35965-29-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

35965-29-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 35965-29-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,9,6 and 5 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 35965-29:
(7*3)+(6*5)+(5*9)+(4*6)+(3*5)+(2*2)+(1*9)=148
148 % 10 = 8
So 35965-29-8 is a valid CAS Registry Number.

35965-29-8Upstream product

35965-29-8Downstream Products

35965-29-8Relevant academic research and scientific papers

Intramolecular Oxidative Arylations in 7-Azaindoles and Pyrroles: Revamping the Synthesis of Fused N-Heterocycle Tethered Fluorenes

Laha, Joydev K.,Bhimpuria, Rohan A.,Hunjan, Mandeep Kaur

, p. 2044 - 2050 (2017)

We revealed intramolecular oxidative arylations in 7-azaindoles and pyrroles that, for the first time, provided direct access to 7-azaindole- or pyrrole-fused isoindolines and tetrahydroisoquinolines. In addition, N-benzylation of 7-azaindoles or pyrroles with sterically hindered sec-benzyl alcohols by Mitsunobu reaction followed by intramolecular oxidative arylation allowed access to chiral congeners of fused isoindolines that have little precedence. A new opportunity in the design and synthesis of fluorene-based organic emitters is demonstrated in the preparation of novel fused N-heterocycle tethered fluorenes, including a chiral fluorene architecture.

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF LEUKOTRIENE PRODUCTION

-

Paragraph 0165; 0166; 0167, (2013/08/14)

The present invention relates to compound of formula (I): or pharmaceutically acceptable salts thereof, wherein R1-R7, A and HET are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 35965-29-8